Bluebird Could Find US Tailwind For Zynteglo After ICER Report

 
• By Alaric DeArment
  
ICER released a revised version of its report on bluebird bio's Zynteglo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies